Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06601842 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Monitoring and Optimization of Cerebral Perfusion Pressure in Post-cardiac Arrest Patients: a Pilot Study

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 11 months later Aug 2026 → Aug 2028
See other at-risk trials from National Taiwan University Hospital

Record History

  1. Primary completion pushed from Aug 2026 to Aug 2028 Completion pushed from Dec 2026 to Dec 2028 · Eligibility criteria expanded, about 13 words · Publications: details revised at 11 of 11 entries Show 3 more changesShow less
    • Completion pushed from Dec 2026 to Dec 2028
    • Eligibility criteria expanded, about 13 words
    • Publications: details revised at 11 of 11 entries
  2. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Sep 2024 to Dec 10, 2024 · Site details revisedv2 Show 2 more changesShow less
    • Start date changed from estimate of Sep 2024 to Dec 10, 2024
    • Site details revised
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this study is to establish the ICP and CPP monitoring process and analyze the results in post-arrest patients, to validate the correlation between direct and non-invasive ICP monitoring indicators, to establish a protocol of management of elevated ICP and insufficient CPP in post-arrest care, to establish a protocol for personalizing CPP and MAP optimization, and to analyze its impact on neuroprognosis. Participants will receive ICP monitoring within 12 hours post-ROSC if meet all inclusion and exclusion criteria.
Trial Details
NCT Number NCT06601842
Lead Sponsor National Taiwan University Hospital
Conditions Cardiac Arrest
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov